RESUMEN
BACKGROUND/AIMS: Although the gastroprotective properties of Ocimum gratissimum L. have been mentioned, the exact mechanism is yet to be explored. Since acid output plays a significant role in the pathogenesis of gastric ulceration, the present study was aimed at investigating the effect of leaf extract of Ocimum gratissimum on gastric luminal pH, acid output, parietal cell mass and gastric mucous cell population in rabbits. MATERIALS AND METHODS: The model of pyloric ligation for acid secretion and ulcer study was employed. Prior to the 4 h ligation, male New Zealand rabbits were treated orally with 75 mg/kg, 150 mg/kg and 250 mg/kg b.w aqueous leaf extract of Ocimum gratissimum twice daily for three weeks. The antisecretory and antiulcer effect of Ocimum gratissimum was compared with omeprazole (20 mg/kg p.o). Parietal cell mass and gastric mucous cell population were determined in the gastric samples by histometry. RESULTS: Aqueous leaf extract of Ocimum gratissimum caused significant reduction in ulcer formation, gastric secretion volume and acid output in a dose dependent manner (p<0.05). Percentage inhibition was recorded as 29%, 46.2%, 52.9% for ulcer; and 16.2%, 35.9%, 52.1% for acid output upon pretreatment with 75 mg/kg, 150 mg/kg and 250 mg/kg b.w respectively. Parietal cell mass was also reduced while gastric mucous cell population and luminal pH increased accordingly when compared to the control group. Data were comparable with the antisecretory effect of omeprazole. CONCLUSION: The results indicate that the anti-secretory activity of Ocimum gratissimum may be the anti-ulcer mechanism of this plant.
Asunto(s)
Tampones (Química) , Ácido Gástrico/metabolismo , Mucosa Gástrica/efectos de los fármacos , Ocimum/química , Células Parietales Gástricas/efectos de los fármacos , Extractos Vegetales/farmacología , Úlcera Gástrica/prevención & control , Animales , Antiulcerosos/farmacología , Mucosa Gástrica/citología , Mucosa Gástrica/metabolismo , Concentración de Iones de Hidrógeno/efectos de los fármacos , Masculino , Omeprazol/farmacología , Hojas de la Planta , ConejosRESUMEN
Trametenolic acid B (TAB), the bioactive component in the Trametes lactinea (Berk.) Pat, was reported to possess cytotoxic activities and thrombin inhibiting effects. This study was performed to investigate the effects of TAB on H(+)/K(+)-ATPase and gastric cancer. The H(+)/K(+)-ATPase inhibitory activity was determined by gastric parietal cells. Compared to the normal control group, TAB (10, 20, 40 and 80 µg/mL) inhibited the H(+)/K(+)-ATPase activity by 15.97, 16.96, 24.86 and 16.25%, respectively. In the study, 36 Kunming mice were randomly divided into six groups: control, model, TAB-L (TAB, 5 mg/kg/day, i.g.), TAB-M (TAB, 20 mg/kg/day, i.g.), TAB-H (TAB, 40 mg/kg/day, i.g.) and omeprazole (OL, 10 mg/kg/day, i.g.). All mice except the control group were administrated with anhydrous alcohol (5.0 mL/kg, i.g.) for induced gastric-ulcer 1h after the 5th day. At the same time, the control mice were given the same volume of physiological saline. After 4h, TAB was evaluated for H(+)/K(+)-ATPase inhibitory activities of ulcerative gaster, gastric ulcer index and ulcer inhibition. In vitro, the anti-proliferation effect of TAB to gastric cancer cell (HGC-27) in acid environment was detected by MTT, and the apoptosis morphological changes were also observed by Hoechst 33258 dye assay. The results indicated that TAB inhibited moderately H(+)/K(+)-ATPase activity in vitro. Compared to the model group, TAB showed anti-ulcer effects in gastric tissue with the dosages of 20 and 5 mg/kg in vivo. Apart from that, TAB could selectively inhibit gastric cancer cell viability and reduce cell apoptosis against HGC-27 cells at low doses in acid environment.
Asunto(s)
ATPasa Intercambiadora de Hidrógeno-Potásio/metabolismo , Fitoterapia , Neoplasias Gástricas/tratamiento farmacológico , Úlcera Gástrica/tratamiento farmacológico , Estómago/efectos de los fármacos , Trametes/química , Triterpenos/uso terapéutico , Animales , Antiulcerosos/química , Antiulcerosos/aislamiento & purificación , Antiulcerosos/farmacología , Antiulcerosos/uso terapéutico , Antineoplásicos Fitogénicos/química , Antineoplásicos Fitogénicos/aislamiento & purificación , Antineoplásicos Fitogénicos/farmacología , Antineoplásicos Fitogénicos/uso terapéutico , Apoptosis/efectos de los fármacos , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Ácido Gástrico/metabolismo , Ratones , Ratones Endogámicos , Omeprazol/farmacología , Células Parietales Gástricas/efectos de los fármacos , Células Parietales Gástricas/enzimología , Extractos Vegetales/química , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Inhibidores de la Bomba de Protones/química , Inhibidores de la Bomba de Protones/aislamiento & purificación , Inhibidores de la Bomba de Protones/farmacología , Inhibidores de la Bomba de Protones/uso terapéutico , Distribución Aleatoria , Estómago/enzimología , Neoplasias Gástricas/enzimología , Úlcera Gástrica/enzimología , Triterpenos/química , Triterpenos/aislamiento & purificación , Triterpenos/farmacologíaRESUMEN
SCOPE: Chlorogenic acid (CA), caffeine (CAFF), pyrogallol (PYR), catechol (CAT), (ß)N-alkanoyl-hydroxytryptamides (C5HT) and N-methylpyridinium (N-MP) were evaluated for their influence on mechanisms of gastric acid secretion as single compounds and in biomimetic mixtures. METHODS AND RESULTS: Compounds were tested in coffee representative concentrations. Human gastric cancer cells (HGT-1) were used to study the proton secretory activity by Ussing chamber experiments and FACS analysis. For activation of EGFr, Akt1, ERK1/2, ATF-2 and cAMP levels, we performed pathway screening assays. Time-dependent expression of related genes were determined by real-time PCR. Part of the data was used for neural network modeling to identify the most relevant compounds. N-MP increased the expression of the anti-secretory somatostatin receptor by 114%, whereas C5HT decreased its expression by 52%. N-MP down-regulated the pro-secretory CHRM3 receptor by 36% and the Hâº,Kâº-ATPase by 36%. CAFF stimulated the secretory activity in the functional assays, whereas N-MP and CA decreased proton secretion. After applying a pathway analysis, we were able to discriminate between CAFF, CA, CAT, C5HT, PYR and histamine-activating EGFr signaling and N-MP-associated ERK1/2 signaling. CONCLUSION: By applying a multi-parametric approach, N-MP was shown to effectively down-regulate mechanisms of gastric acid secretion in human parietal gastric cells.
Asunto(s)
Café/efectos adversos , Café/química , Ácido Gástrico/metabolismo , Células Parietales Gástricas/efectos de los fármacos , Factor de Transcripción Activador 2/genética , Factor de Transcripción Activador 2/metabolismo , Alcaloides/farmacología , Cafeína/farmacología , Catecoles/farmacología , Línea Celular Tumoral , Ácido Clorogénico/farmacología , AMP Cíclico/metabolismo , Regulación hacia Abajo , Sinergismo Farmacológico , Regulación de la Expresión Génica/efectos de los fármacos , ATPasa Intercambiadora de Hidrógeno-Potásio/genética , ATPasa Intercambiadora de Hidrógeno-Potásio/metabolismo , Humanos , Células Parietales Gástricas/metabolismo , Protones , Compuestos de Piridinio/farmacología , Pirogalol/farmacología , Receptores de Somatostatina/genética , Receptores de Somatostatina/metabolismoRESUMEN
OBJECTIVE: To study the regulative action of mica monomer powder preparation on the chief and parietal cells as well as G and D cells in the gastric mucosa of the experimental atrophic gastritis (CAG) rats. METHODS: Intervention therapy was given to the experimental CAG rats at three different doses of mica monomer powder preparation to evaluate the changes of chief and parietal cells as well as G and D cells in the gastric mucosa and the histopathological changes of gastric mucosa. RESULTS: Mica monomer powder preparation at three different doses could increase the amount of chief and parietal cells as well as G and D cells in gastric mucosa of the experimental CAG rats and alleviate and control the inflammation of gastric mucosa and the atrophy of gastric mucosa glands. Especially, better effects were shown in the mid and high dose groups. CONCLUSION: Mica has the pharmacological action of protecting the gastric mucosa, enhancing blood flow of the gastric mucosa, and consequently improving the inflammatory responses of the gastric mucosa. One of the mechanisms is associated with promoting the secretion of gastric acid and gastric pepsin and regulating the neuroendocrine mechanism including gut hormone secretion (gastrin and somatostatin) by increasing the number of chief and parietal cells as well as G and D cells.
Asunto(s)
Silicatos de Aluminio/farmacología , Mucosa Gástrica/efectos de los fármacos , Mucosa Gástrica/patología , Gastritis Atrófica/patología , Animales , Recuento de Células , Células Principales Gástricas/efectos de los fármacos , Células Principales Gástricas/patología , Enfermedad Crónica , Células Secretoras de Gastrina/efectos de los fármacos , Células Secretoras de Gastrina/patología , Inflamación , Células Parietales Gástricas/efectos de los fármacos , Células Parietales Gástricas/patología , Polvos , Ratas , Ratas Sprague-Dawley , Células Secretoras de Somatostatina/efectos de los fármacos , Células Secretoras de Somatostatina/patologíaRESUMEN
Baby formula acidification can be used to reduce diarrhea. Calcium formate is a dietary acidifier frequently used in animal weaning diets; it is also a source of available calcium. Gastric acidification reduces gastrin release and hydrochloric acid (HCl) secretion. To study the medium-term effects on fundic gastric mucosa, we fed weaning pigs control diets or diets supplemented with free or fat-protected calcium formate. We evaluated the following: 1) the number of HCl-secreting parietal cells, by immunohistochemistry using an antibody against H(+)/K(+)-ATPase; 2) the number of enteroendocrine cells immunohistochemically stained with chromogranin A (CGA), somatostatin, and histamine (HIS); and 3) the expression of the H(+)/K(+)-ATPase gene, by real-time RT-PCR in the oxyntic mucosa. Cells co-staining for CGA and HIS were defined as enterochromaffin-like (ECL) cells. Pigs fed calcium formate had fewer parietal cells and a lower expression of the H(+)/K(+)-ATPase gene than the controls (P < 0.05). This reduction did not occur in pigs fed fat-protected calcium formate. Somatostatin immune-reactive cells were also more numerous in pigs fed free calcium formate than in controls (P < 0.05). The number of ECL cells was not affected. Using covariance analysis, the number of parietal cells explained part of the differences in the expression of H(+)/K(+)-ATPase gene (positive correlation, r = 0.385, P < 0.01), and excluded the statistical significance of the diet. In the future, the effects on the oxyntic mucosa should be checked when the diet supplemented with calcium formate is discontinued. Furthermore, a reduction in the number of parietal cells could impair the absorption of vitamin B-12 due to a reduced secretion of the intrinsic factor by these cells.
Asunto(s)
Calcio de la Dieta/farmacología , ATPasa Intercambiadora de Hidrógeno-Potásio/genética , Células Parietales Gástricas/citología , Alimentación Animal , Animales , Recuento de Células , Dieta , Ácido Gástrico/metabolismo , Gastrinas/metabolismo , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Inmunohistoquímica , Células Parietales Gástricas/efectos de los fármacos , Células Parietales Gástricas/enzimología , Estómago , Porcinos , DesteteRESUMEN
PURPOSE: Long-term administration of PPI causes hyperplastic changes of the gastric parietal cells; however, the detailed mechanism remains to be clarified. We administered high-dose omeprazole to patients with Barrett's esophagus for 2 years, and investigated changes in gastric ECL (Enterochromaffin-like) cells using endoscopic biopsy specimens to clarify the etiology of hyperplasia of the parietal cells. METHODS: The subjects were 69 patients who were diagnosed as having Barrett's esophagus (39 males, 30 females). We established two groups, an omeprazole-treated group and a ranitidine-treated group. Upper digestive tract endoscopy was performed before administration, and 12 and 24 months after the start of administration. Biopsy was performed in the greater curvature of the gastric body. The ECL/parietal cell counts and the grade of hyperplasia of the gastric mucosa were determined under a microscope. In addition, the fasting serum gastrin level was measured, and statistical analysis was performed. RESULTS: In the omeprazole-treated group, the ECL cell count was markedly increased 12 months after the start of administration, but was lower than the pretreatment value 24 months after the start of administration. The parietal and ECL cell counts significantly increased. Furthermore, there were no changes in mucosa thickness. The fasting serum gastrin level significantly increased. In the ranitidine-treated group, there was no increase in the ECL cell count, and the parietal cell count was decreased. There was no significant increase in mucosa thickness. The fasting serum gastrin level increased, although the rate of increase was markedly smaller than that in the omeprazole-treated group. CONCLUSION: Not the direct pharmacological actions of PPI but hypergastrinemia-associated secondary changes may be etiologically involved in hyperplasia of the parietal cells related to long-term administration of PPI.
Asunto(s)
Antiulcerosos/efectos adversos , Esófago de Barrett/tratamiento farmacológico , Células Enterocromafines/efectos de los fármacos , Omeprazol/efectos adversos , Células Parietales Gástricas/efectos de los fármacos , Antiulcerosos/administración & dosificación , Antiulcerosos/uso terapéutico , Esófago de Barrett/metabolismo , Esófago de Barrett/patología , Recuento de Células , Relación Dosis-Respuesta a Droga , Células Enterocromafines/metabolismo , Células Enterocromafines/patología , Femenino , Gastrinas/metabolismo , Gastroscopía , Humanos , Hiperplasia , Masculino , Omeprazol/administración & dosificación , Omeprazol/uso terapéutico , Células Parietales Gástricas/metabolismo , Células Parietales Gástricas/patología , Inhibidores de la Bomba de Protones , Factores de TiempoRESUMEN
OBJECTIVE: To study the effects of Dangshen root extract on intracellular free calcium concentration [Ca2+] i of parietal cells. METHODS: The Dangshen-containing serum was obtained from rat blood after a continuously five days' feeding with Dangshen root extract of three doses and parietal cells were isolated from Sprague-Dawley rats; [Ca2+] i in single cells was measured by confocal microscope loaded with Fluo3-AM as fluorensent indicator; The change of [Ca2+] i was represented by fluorensent intensity (FI). RESULTS: There were differences in the FI of [Ca2+] i increased by gastrin both between high and control group and between middle and control group (P < 0.05). But no difference was found between low and control groups (P > 0.05). And time to peak of FI, it was not found any difference between any two of the groups. CONCLUSION: Dangshen-containing serum can inhibit the intracellular [Ca2+] i increase induced by gastrin in a dose-dependent manner and it may be one of the mechanisms of its reduction on acid secretion which has a close relation with the formation of ulcerous diseases.
Asunto(s)
Calcio/metabolismo , Codonopsis/química , Medicamentos Herbarios Chinos/farmacología , Células Parietales Gástricas/efectos de los fármacos , Plantas Medicinales/química , Animales , Citosol/metabolismo , Medicamentos Herbarios Chinos/administración & dosificación , Ácido Gástrico/metabolismo , Microscopía Confocal , Células Parietales Gástricas/citología , Células Parietales Gástricas/metabolismo , Raíces de Plantas/química , Ratas , Ratas Sprague-Dawley , Úlcera Gástrica/tratamiento farmacológico , Úlcera Gástrica/patologíaRESUMEN
BACKGROUND: Interleukin 1beta (IL-1beta) is a potent inhibitor of gastric acid secretion. Regulatory actions at several levels have previously been demonstrated, including direct inhibition of parietal cell acid secretion. Although IL-1beta may activate several intracellular signalling pathways, the mechanisms responsible for inhibition of carbachol stimulated acid secretion have not been determined. AIMS: To investigate the roles of protein kinase C (PKC) and the sphingomyelinase signalling pathways in the regulation of acid secretion by IL-1beta. METHODS: Rabbit parietal cells were obtained by collagenase-EDTA digestion and centrifugal elutriation. Acid secretion stimulated by carbachol and A23187 (to mimic elevations in intracellular calcium) was assessed by 14C aminopyrine uptake in response to IL-1beta, PKC, and sphingomyelinase manipulation. RESULTS: IL-1beta inhibited carbachol and A23187 stimulated acid secretion in a dose dependent manner. The inhibitory actions were completely reversed by each of three different PKC inhibitors, staurosporine, H-7, and chelerythrine, as well as by PKC depletion with high dose phorbol ester pretreatment. IL-1beta did not downregulate parietal cell muscarinic receptor. IL-1beta significantly increased membrane PKC activity. Activation of the sphingomyelinase/ceramide pathway had no effect on basal or stimulated acid secretion. The inhibitory action of IL-1beta was independent of protein kinase A and protein kinase G activity. CONCLUSIONS: IL-1beta directly inhibits parietal cell carbachol stimulated acid secretion. This action occurs distal to muscarinic receptor activation and elevations in intracellular calcium and requires PKC.
Asunto(s)
Carbacol/farmacología , Agonistas Colinérgicos/farmacología , Ácido Gástrico/fisiología , Interleucina-1/fisiología , Células Parietales Gástricas/efectos de los fármacos , Proteína Quinasa C/fisiología , 1-(5-Isoquinolinesulfonil)-2-Metilpiperazina/farmacología , Alcaloides , Análisis de Varianza , Animales , Benzofenantridinas , Carbacol/antagonistas & inhibidores , Carcinógenos/farmacología , Comunicación Celular/fisiología , Células Cultivadas , Relación Dosis-Respuesta a Droga , Inhibidores Enzimáticos/farmacología , Células Parietales Gástricas/fisiología , Fenantridinas/farmacología , Conejos , Esfingomielina Fosfodiesterasa/fisiología , Estaurosporina/farmacología , Acetato de Tetradecanoilforbol/farmacologíaRESUMEN
The common lipopolysaccharide (LPS)-induced gastric lesions, such as erosions or ulcers, have been investigated in depth. Little is known, however, about the acute gastric lesions following a high dose of LPS. In a time-course study, ICR female mice were given a high subcutaneous dose of LPS (50 mg/kg). Mice were sacrificed at 4, 6, 12, and 24 hours after dosing and were assessed histopathologically for acute gastric lesions. The major gastric changes were seen in the fundic region and included vacuolar degeneration of parietal cells and apoptosis of chief cells. The vacuole in parietal cells was apparent as early as 4 hours postinjection (PI), and apoptosis of chief cells was apparent at 12 hours PI. Thrombus formation, in contrast, was not seen until 24 hours PI. No erosion, ulcer, or hemorrhage was seen in any gastric region in any of the treated animals at 24 hours PI. These results indicate that a subcutaneous high dose of LPS in mice causes vacuolar degeneration of parietal cells and apoptosis of chief cells before thrombus formation or subsequent ulcerative lesions.
Asunto(s)
Células Principales Gástricas/efectos de los fármacos , Escherichia coli , Lipopolisacáridos/toxicidad , Células Parietales Gástricas/efectos de los fármacos , Trombosis/inducido químicamente , Enfermedad Aguda , Animales , Apoptosis/efectos de los fármacos , Recuento de Células Sanguíneas/efectos de los fármacos , Temperatura Corporal/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Células Principales Gástricas/química , Células Principales Gástricas/patología , Gránulos Citoplasmáticos/química , Femenino , ATPasa Intercambiadora de Hidrógeno-Potásio/análisis , Inmunohistoquímica , Etiquetado Corte-Fin in Situ , Ratones , Ratones Endogámicos ICR , Células Parietales Gástricas/química , Células Parietales Gástricas/patología , Pepsina A/análisis , Trombosis/patologíaRESUMEN
Phytochemical and pharmacological studies of Croton cajucara were oriented by traditional medicine. The stem bark of the mature plant is a rich source of clerodane-type diterpenes: trans-dehydrocrotonin (DCTN), trans-crotonin (CTN), cis-cajucarin B, cajucarin A, cajucarinolide and two novel clerodanes, trans-cajucarin B and sacacarin. In young (18-month-old) plants, the triterpene acetyl aleuritolic acid (AAA) was the major stem bark component and in these the diterpene DCTN was not present. The highest concentration of DCTN (1.4% of dry bark) was detected in 4-6 year-old plants, while 3-year-old plants contained only 0.26% of this diterpene. Three steroids (beta-sitosterol, stigmasterol and sitosterol-3-O-beta-glucoside), two flavonoids (kaempferol 3,4', 7-trimethyl ether and 3,7-dimethyl ether) and one diterpene (cajucarinolide) were isolated from the leaves of this Croton. The main pharmacological activity was correlated with DCTN. This clerodane produced anti-inflammatory and antinociceptive effects and a significant hypoglycemia in alloxan-induced diabetic rats. The compound also reduced the index of gastric lesions induced by restraint-in-cold. Dose-related DCTN and CTN inhibited in vivo the basal acid secretion in pylorus-ligature rats and oxyntic glands isolated from rabbit gastric mucosa, DCTN, CTN or AAA decreased in vitro uptake basal acid secretion induced by histamine and measured with the 14C-aminopyrine uptake method. Uniquely DCTN inhibited 14C-AP uptake induced by bethanechol. The terpenoids, DCTN and AAA, and the chloroform extract of 6-month-old plants reduced gastrointestinal transit in mice. The effects of DCTN and CTN on the survival of mice bearing Sarcoma 180 and Ehrlich carcinoma ascitic tumors, on the proliferation of cultured cells and TNFalpha were determined. DCTN was also evaluated for a possible antioestrogenic activity using the immature rat as a model system for bioassay of oestrogen and for an anti-implantation effect in regularly cycling rats. The biological experiments, using the plant extracts and the terpenoids DCTN, CTN and AAA, are herein discussed.
Asunto(s)
Etnobotánica , Plantas Medicinales/química , Animales , Antiulcerosos/aislamiento & purificación , Antiulcerosos/farmacología , Antineoplásicos Fitogénicos/aislamiento & purificación , Antineoplásicos Fitogénicos/farmacología , Brasil , Antagonistas de Estrógenos/aislamiento & purificación , Antagonistas de Estrógenos/farmacología , Femenino , Ácido Gástrico/metabolismo , Fármacos Gastrointestinales/aislamiento & purificación , Fármacos Gastrointestinales/farmacología , Tránsito Gastrointestinal/efectos de los fármacos , Técnicas In Vitro , Masculino , Medicina Tradicional , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones Endogámicos DBA , Células Parietales Gástricas/efectos de los fármacos , Extractos Vegetales/química , Extractos Vegetales/farmacología , Plantas Medicinales/crecimiento & desarrollo , Conejos , Ratas , Ratas Wistar , SolventesRESUMEN
The H,K-adenosine triphosphatase (ATPase) of gastric parietal cells is targeted to a regulated membrane compartment that fuses with the apical plasma membrane in response to secretagogue stimulation. Previous work has demonstrated that the alpha subunit of the H, K-ATPase encodes localization information responsible for this pump's apical distribution, whereas the beta subunit carries the signal responsible for the cessation of acid secretion through the retrieval of the pump from the surface to the regulated intracellular compartment. By analyzing the sorting behaviors of a number of chimeric pumps composed of complementary portions of the H, K-ATPase alpha subunit and the highly homologous Na,K-ATPase alpha subunit, we have identified a portion of the gastric H,K-ATPase, which is sufficient to redirect the normally basolateral Na,K-ATPase to the apical surface in transfected epithelial cells. This motif resides within the fourth of the H,K-ATPase alpha subunit's ten predicted transmembrane domains. Although interactions with glycosphingolipid-rich membrane domains have been proposed to play an important role in the targeting of several apical membrane proteins, the apically located chimeras are not found in detergent-insoluble complexes, which are typically enriched in glycosphingolipids. Furthermore, a chimera incorporating the Na, K-ATPase alpha subunit fourth transmembrane domain is apically targeted when both of its flanking sequences derive from H,K-ATPase sequence. These results provide the identification of a defined apical localization signal in a polytopic membrane transport protein, and suggest that this signal functions through conformational interactions between the fourth transmembrane spanning segment and its surrounding sequence domains.
Asunto(s)
Membrana Celular/enzimología , Polaridad Celular , ATPasa Intercambiadora de Hidrógeno-Potásio/análisis , ATPasa Intercambiadora de Hidrógeno-Potásio/química , Células Parietales Gástricas/enzimología , Señales de Clasificación de Proteína/fisiología , Secuencia de Aminoácidos , Animales , Transporte Biológico , Cationes/metabolismo , Línea Celular , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Glicoesfingolípidos/metabolismo , Glicosilfosfatidilinositoles/metabolismo , ATPasa Intercambiadora de Hidrógeno-Potásio/genética , ATPasa Intercambiadora de Hidrógeno-Potásio/metabolismo , Concentración de Iones de Hidrógeno , Proteínas de la Membrana/análisis , Proteínas de la Membrana/química , Proteínas de la Membrana/genética , Proteínas de la Membrana/metabolismo , Datos de Secuencia Molecular , Ouabaína/farmacología , Células Parietales Gástricas/citología , Células Parietales Gástricas/efectos de los fármacos , Células Parietales Gástricas/metabolismo , Señales de Clasificación de Proteína/química , Señales de Clasificación de Proteína/genética , Proteínas Recombinantes de Fusión/análisis , Proteínas Recombinantes de Fusión/química , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Alineación de Secuencia , Eliminación de Secuencia/genética , ATPasa Intercambiadora de Sodio-Potasio/antagonistas & inhibidores , ATPasa Intercambiadora de Sodio-Potasio/química , ATPasa Intercambiadora de Sodio-Potasio/genética , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Solubilidad , TransfecciónRESUMEN
We purified a compound with strong inhibitory effect on H+, K(+)-ATPase from Paeoniae radix, which has been used in Japan for the treatment of gastritis and peptic ulcers. The compound was identified as 1,2,3,4,6,-penta-o-galloyl-beta-D-glucose by proton nuclear magnetic resonance, carbon-13 nuclear magnetic resonance, and fast atomic bombardment mass spectrometry. The IC50 of the compound for H+, K(+)-ATPase was 166 nmol/l. Kinetic analyses indicated that the inhibition of the enzyme by pentagalloylglucose was noncompetitive with respect to K+. Pentagalloylglucose had relatively weak inhibitory effects for Mg(+)-ATPase (IC50: > 10 mumol/l) and Na+, K(+)-ATPase (IC50: 2.7 mumol/l). Pentagalloylglucose also inhibited the accumulation of [14C]aminopyrine in parietal cells that had been isolated from guinea pig stomach and stimulated by 10 mumol/l histamine (IC50: 7.8 mumol/l) and 1 mmol/l dbc-AMP (IC50: 10 mumol/l). These results suggest that pentagalloylglucose is a potent inhibitor of H+, K(+)-ATPase and may be responsible for inhibition of acid secretion by Paeoniae radix.
Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Taninos Hidrolizables , Células Parietales Gástricas/enzimología , Inhibidores de la Bomba de Protones , Taninos/farmacología , Aminopirina/antagonistas & inhibidores , Animales , ATPasa de Ca(2+) y Mg(2+)/antagonistas & inhibidores , Células Cultivadas , Inhibidores Enzimáticos/farmacología , Ácido Gástrico/metabolismo , Cobayas , Japón , Cinética , Masculino , Células Parietales Gástricas/efectos de los fármacos , Células Parietales Gástricas/metabolismo , Taninos/aislamiento & purificaciónRESUMEN
BACKGROUND & AIMS: Parietal cells express heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF). However, it is unknown whether HB-EGF mediates the trophic action of gastrin. The purpose of this study was to determine whether gastrin modulates the expression of HB-EGF, which mediates the proliferative effects of gastrin on gastric epithelial cells. METHODS: RGM1 cells, a rat gastric epithelial cell line, were transfected with a human gastrin receptor complementary DNA. Gastrin induction of messenger RNAs (mRNAs) for EGF-related polypeptides was assayed by Northern blotting. Processing of cell surface-associated proHB-EGF and secretion of HB-EGF were determined by flow cytometry and Western blotting, respectively. Tyrosine phosphorylation of the EGF receptor was assayed by immunoprecipitation and Western blotting with an antiphosphotyrosine antibody. Cell growth was evaluated by [3H]thymidine incorporation. RESULTS: Gastrin induced expression of HB-EGF mRNA, processing of proHB-EGF, release of HB-EGF into the medium, and tyrosine phosphorylation of the EGF receptor. The growth-stimulatory effects of gastrin were partly inhibited by anti-rat HB-EGF serum and completely blocked by AG1478, an EGF receptor-specific tyrphostin. CONCLUSIONS: The findings suggest that HB-EGF at least partially mediates the proliferative effects of gastrin on gastric epithelial cells.
Asunto(s)
Factor de Crecimiento Epidérmico/biosíntesis , Células Epiteliales/metabolismo , Mucosa Gástrica/metabolismo , Gastrinas/farmacología , Heparina/metabolismo , Receptores de Colecistoquinina/biosíntesis , Animales , Northern Blotting , Western Blotting , División Celular/efectos de los fármacos , Línea Celular , Factor de Crecimiento Epidérmico/metabolismo , Células Epiteliales/efectos de los fármacos , Mucosa Gástrica/citología , Mucosa Gástrica/efectos de los fármacos , Cobayas , Factor de Crecimiento Similar a EGF de Unión a Heparina , Humanos , Péptidos y Proteínas de Señalización Intercelular , Masculino , Células Parietales Gástricas/efectos de los fármacos , Células Parietales Gástricas/metabolismo , Fosforilación , Pruebas de Precipitina , ARN Mensajero/biosíntesis , Ratas , Receptor de Colecistoquinina B , Receptores de Colecistoquinina/genética , Transfección , Tirosina/metabolismoRESUMEN
The ECL cells are histamine- and pancreastatin-secreting endocrine cells in the oxyntic mucosa, thought to release a blood Ca2+-lowering peptide hormone upon stimulation by gastrin. Previously, we have shown that the ECL cells do not respond to perturbations in blood Ca2+. In the present study, we examine if Ca2+ in the gastric lumen will affect the activity of the gastrin-ECL-cell axis. Freely fed or food deprived (48 h) rats were given an oral load of CaCl2 (or NaCl), and the blood Ca2+ concentration was monitored. The serum gastrin concentration at sacrifice, 3 h after ingestion of CaCl2, was measured together with two parameters of ECL cell activity: the oxyntic mucosal histidine decarboxylase (HDC) activity and the serum pancreastatin concentration. The circulating concentrations of calcitonin and parathyroid hormone (PTH) were also measured. Oral CaCl2 raised the blood Ca2+ in a dose-dependent manner. The two highest doses (which caused damage to the oxyntic mucosa) raised the serum gastrin concentration and the HDC activity in both fed and fasted rats; the serum pancreastatin concentration remained unaffected. Oral CaCl2 raised the serum calcitonin concentration and lowered the serum PTH concentration. The effects of high doses of oral CaCl2 on the serum gastrin concentration and on the oxyntic mucosal HDC activity could be reproduced by a high dose of NaCl. Thus the effects are probably not due to Ca2+ per se. We conclude that the gastrin-ECL-cell axis in the rat does not respond to peroral Ca2+. Since the ECL cells do not respond to either circulating or peroral Ca2+ they are unlikely to secrete a calciotropic hormone.
Asunto(s)
Cloruro de Calcio/farmacología , Gastrinas/efectos de los fármacos , Células Parietales Gástricas/efectos de los fármacos , Administración Oral , Animales , Calcitonina/sangre , Calcitonina/efectos de los fármacos , Calcio/sangre , Cloruro de Calcio/administración & dosificación , Cromogranina A , Relación Dosis-Respuesta a Droga , Mucosa Gástrica/citología , Mucosa Gástrica/efectos de los fármacos , Gastrinas/sangre , Histidina Descarboxilasa/efectos de los fármacos , Histidina Descarboxilasa/metabolismo , Masculino , Hormonas Pancreáticas/sangre , Hormona Paratiroidea/sangre , Células Parietales Gástricas/metabolismo , Ratas , Ratas Sprague-Dawley , Cloruro de Sodio/farmacologíaRESUMEN
We investigated the therapeutic effects of egualen sodium (KT1-32), a new antiulcer agent, on chronic erosive and atrophic gastritis induced by 5 months' administration of sodium taurocholate (TCA; 5 mM) in rats. The chronic gastritis was manifested by mucosal surface injuries (erosions), reduced mucosal thickness, reduction of the number of parietal cells, infiltration of inflammatory cells, and proliferation of collagenous fiber. Egualen sodium, (10-100 mg/kg, t.i.d.) administered orally to the rats for 2 weeks after the withdrawal of TCA, dose-dependently and significantly decreased the total length of erosions. The indicators of atrophic gastritis, i.e., reduced mucosal thickness and reduction in the number of parietal cells, were improved dose-dependently by the administration of this agent. Egualen sodium also reduced the inflammatory cell infiltration and the proliferation of collagenous fiber in the gastric mucosa in a dose-dependent manner. The reduced staining of neutral gastric mucus was improved by a high dose (100 mg/kg) of egualen sodium. The therapeutic effects of egualen sodium on experimental gastritis were superior to those of sofalcone and sodium guaiazulene 3-sulfonate. These results suggest that egualen sodium may be a promising agent for the treatment of erosive and atrophic gastritis.
Asunto(s)
Antiulcerosos/farmacología , Mucosa Gástrica/efectos de los fármacos , Gastritis/tratamiento farmacológico , Sesquiterpenos/farmacología , Administración Oral , Animales , Antiinfecciosos/administración & dosificación , Antiinfecciosos/farmacología , Antiinfecciosos/uso terapéutico , Antiulcerosos/administración & dosificación , Antiulcerosos/uso terapéutico , Azulenos , Recuento de Células , División Celular/efectos de los fármacos , Chalcona/administración & dosificación , Chalcona/análogos & derivados , Chalcona/farmacología , Chalcona/uso terapéutico , Chalconas , Enfermedad Crónica , Relación Dosis-Respuesta a Droga , Mucosa Gástrica/metabolismo , Mucosa Gástrica/patología , Gastritis/inducido químicamente , Gastritis/patología , Masculino , Moco/metabolismo , Células Parietales Gástricas/efectos de los fármacos , Células Parietales Gástricas/patología , Ratas , Ratas Wistar , Sesquiterpenos/administración & dosificación , Sesquiterpenos/uso terapéutico , Sesquiterpenos de Guayano , Ácido Taurocólico , Resultado del TratamientoRESUMEN
Biologically active amidated gastrin is synthesized by carboxyl-terminal alpha-amidation of a glycine-extended progastrin post-translational processing intermediate (G-Gly). Although plasma levels of G-Gly are equivalent to those of gastrin, G-Gly has essentially no acute effect on gastric acid secretion. However, we have observed that inhibition of gastrin amidation leads to increased plasma concentrations of G-Gly and enhanced gastric acid secretion. We hypothesized, therefore, that G-Gly might have a chronic effect to increase H+,K(+)-ATPase expression in gastric parietal cells. In the present studies, we observed that a 2-day preincubation with G-Gly significantly enhanced histamine-stimulated [14C]aminopyrine uptake by isolated canine gastric parietal cells but acutely administered G-Gly had no effect. On Northern blot analysis, both G-Gly and gastrin dose-dependently increased H+,K(+)-ATPase alpha-subunit gene expression with maximal induction (225 +/- 35 and 170 +/- 29% of basal, mean +/- S.E.) achieved at concentrations of 10(-9) M G-Gly and 10(-8) M gastrin, respectively. Using an H+,K(+)-ATPase alpha-subunit gene-luciferase chimeric reporter construct transfected into primary cultured parietal cells, we observed that both G-Gly and gastrin increased luciferase activity in a manner similar to that obtained by Northern blot analysis. L365,260, a specific gastrin/CCKB receptor antagonist, completely reversed the stimulation of luciferase activity induced by gastrin but had no effect on G-Gly-stimulated activity. Gastrin increased [Ca2+]i, although G-Gly did not, however, genistein (a tyrosine kinase inhibitor) significantly reduced induction of luciferase activity by both G-Gly and gastrin. Specific binding of 125I-Leu15-G2-17-Gly to gastric parietal cells was dose-dependently displaced by G2-17-Gly but not by gastrin nor L365,260. Gastrin peptides truncated at the carboxyl- (G1-13) and amino terminus (G5-17-Gly) both induced H+,K(+)-ATPase alpha-subunit gene expression and inhibited 125I-Leu15-G2-17-Gly binding, but were less potent than G2-17-Gly. These data indicate that G-Gly may have a functional role in potentiating gastric acid secretagogue action via enhanced expression of the gene responsible for H+ generation through action at a novel receptor that can be distinguished from the gastrin/CCKB receptor. Thus, both the substrate and product of the terminal progastrin processing reaction appear to have complementary functions in regulation of gastric acid secretion.
Asunto(s)
Gastrinas/metabolismo , Gastrinas/farmacología , Expresión Génica/efectos de los fármacos , Glicina/metabolismo , ATPasa Intercambiadora de Hidrógeno-Potásio/biosíntesis , Células Parietales Gástricas/metabolismo , Compuestos de Fenilurea , Precursores de Proteínas/metabolismo , Precursores de Proteínas/farmacología , Procesamiento Proteico-Postraduccional , Aminopirina/metabolismo , Animales , Secuencia de Bases , Benzodiazepinonas/farmacología , Transporte Biológico , Northern Blotting , Calcio/metabolismo , Células Cultivadas , Perros , Relación Dosis-Respuesta a Droga , Inducción Enzimática , Histamina/farmacología , Humanos , Cinética , Luciferasas/biosíntesis , Sustancias Macromoleculares , Datos de Secuencia Molecular , Células Parietales Gástricas/efectos de los fármacos , Células Parietales Gástricas/enzimología , Regiones Promotoras Genéticas , Receptores de Colecistoquinina/antagonistas & inhibidores , Proteínas Recombinantes de Fusión/biosíntesis , Transfección , beta-Galactosidasa/biosíntesisRESUMEN
The oxyntic mucosa in the rat stomach is under the influence of circulating gastrin. The histamine-producing enterochromaffin-like (ECL) cells constitute the major endocrine cell population in the oxyntic mucosa. They are notably sensitive to changes in the serum gastrin concentration and respond to long-term hypergastrinemia with hyperplasia, whereas hypogastrinemia induces hypoplasia. In the present study long-term, sustained hypergastrinemia was induced by daily treatment with a high dose of the proton pump inhibitor omeprazole. After 10 weeks omeprazole-treated and control rats were antrectomized, resulting in prompt hypogastrinemia. Antrectomy was followed by a rapid reduction of the thickness of the oxyntic mucosa and a somewhat slower reduction of the ECL cell number in both omeprazole-treated and control rats. The percentage decrease in the ECL cell number with time was similar in both groups; after 2-3 weeks the ECL cell number was half of that before antrectomy in both groups. Interestingly, however, 12 weeks after antrectomy the ECL cell number in the omeprazole-pretreated rats remained elevated compared with untreated rats. The histamine concentration of the oxyntic mucosa was markedly lowered within a week after antrectomy in both omeprazole-treated and control rats. Although antrectomy induces hypogastrinemia and although atrophy develops rapidly in the oxyntic mucosa, the omeprazole-induced ECL cell hyperplasia was not completely reversed by antrectomy during the 12 weeks of examination.
Asunto(s)
Gastrinas/sangre , Omeprazol/farmacología , Células Parietales Gástricas/efectos de los fármacos , Antro Pilórico/cirugía , Animales , Atrofia , Recuento de Células , Supervivencia Celular , Mucosa Gástrica/efectos de los fármacos , Mucosa Gástrica/patología , Hiperplasia , Masculino , Células Parietales Gástricas/patología , Ratas , Ratas EndogámicasRESUMEN
Acid secretory responses and parietal cell sensitivity (PCS) have been studied in 21 duodenal ulcer patients before and after successful treatment with omeprazole (n = 7), sucralfate (n = 7), or Maalox (n = 7). The second study was carried out 3 days after documented healing and withdrawal of treatment in the sucralfate- and Maalox-treated groups and 14 days after documented healing and withdrawal of treatment in the omeprazole-treated patients. Acid output (mmol/hour) was measured as basal secretion, and in response to 0.1 microgram/kg/hour pentagastrin (low-dose) and 6.0 micrograms/kg/hour pentagastrin (high-dose) stimulation. PCS was calculated as the ratio of low dose:high dose acid output (expressed as a percentage). Ulcer healing with sucralfate resulted in significant (p less than 0.05) decreases in low-dose acid output from 36.4% (13.2-51.0) (median [range]) to 8.4% (3.2-45.4) mmol/hour and PCS from 69.1% (44.9-91.4) to 22.0% (16.0-85.6), whereas no significant decreases in any of the measured parameters were noted following ulcer healing with Maalox. Ulcer healing with omeprazole resulted in significant (p less than 0.05) decreases in basal acid output from 6.3 (1.5-22.9) (median [range]) to 2.2 (0-6.9) mmol/hour, and low-dose acid output from 31.0 (6.0-58.0) to 23.0 (1.4-44.8) mmol/hour. These findings suggest that acid secretory responses following ulcer healing vary according to the therapeutic agent used.
Asunto(s)
Hidróxido de Aluminio/uso terapéutico , Antiácidos/uso terapéutico , Úlcera Duodenal/tratamiento farmacológico , Ácido Gástrico/metabolismo , Hidróxido de Magnesio/uso terapéutico , Omeprazol/uso terapéutico , Células Parietales Gástricas/efectos de los fármacos , Sucralfato/uso terapéutico , Cicatrización de Heridas/efectos de los fármacos , Adulto , Anciano , Hidróxido de Aluminio/farmacología , Antiácidos/farmacología , Combinación de Medicamentos , Úlcera Duodenal/sangre , Úlcera Duodenal/diagnóstico , Endoscopía Gastrointestinal , Ayuno , Femenino , Determinación de la Acidez Gástrica , Gastrinas/sangre , Humanos , Hidróxido de Magnesio/farmacología , Masculino , Persona de Mediana Edad , Omeprazol/farmacología , Pentagastrina , Recurrencia , Sucralfato/farmacologíaRESUMEN
The effects of the anti-inflammatory seleno-organic compound ebselen on gastric H+/K(+)-ATPase, H+/K(+)-ATPase-mediated proton transport and on parietal cell HCl production was studied. Ebselen inhibited K(+)-stimulated ATPase activity in leaky gastric membranes (IC50:0.15 microM) and H+/K(+)-ATPase-mediated proton transport in intact gastric membrane vesicles (IC50:0.7 microM). Histamine- and dibutyryl-cAMP-stimulated HCl production in isolated and enriched guinea-pig parietal cells was inhibited with an IC50 value of 12 microM. The mercaptan dithioerythritol and the nucleotide ATP prevents the H+/K(+)-ATPase against inactivation and dithioerythritol was found to restore already inhibited enzyme activity and ATPase mediated H+ transport. Furthermore, dithioerythritol could prevent ebselen-induced inhibition of HCl production in the parietal cell preparation. It is concluded that ebselen inhibits acid secretion in the parietal cell by interference with SH groups of the gastric proton pump, the H+/K(+)-ATPase. Therefore ebselen can be regarded as an anti-inflammatory drug for which in vitro anti-secretory properties can be demonstrated.
Asunto(s)
Adenosina Trifosfatasas/metabolismo , Antiinflamatorios no Esteroideos/farmacología , Azoles/farmacología , Ácido Gástrico/metabolismo , Compuestos de Organoselenio , Células Parietales Gástricas/efectos de los fármacos , Selenio/farmacología , Estómago/enzimología , Animales , Transporte Biológico Activo/efectos de los fármacos , Perros , Cobayas , ATPasa Intercambiadora de Hidrógeno-Potásio , Isoindoles , Riñón/enzimología , Células Parietales Gástricas/metabolismo , Protones , PorcinosRESUMEN
36 patients with chronic gastric or oesophageal peptic ulceration (including 6 with antrectomy), resistant to high-dose ranitidine treatment for at least 3 months, were successfully treated with 40-60 mg of omeprazole daily for periods between 1 and 2 years. Fasting serum gastrin levels were monitored at regular intervals during therapy and multiple gastric mucosal biopsies were taken during gastroscopy every 3-6 months. Gastrin levels increased significantly during the first 6 months of therapy from a medium level of 81.5 to 206 pg/ml, a slight decrease was seen thereafter. In 10 patients investigated before the start of the treatment and after 1 and 2 years, the volume density of argyrophilic cells in the oxyntic mucosa increased from 0.43 +/- 0.08 to 0.91 +/- 0.14% during the first year; this change was statistically significant. No further increase was observed thereafter. No such difference could be demonstrated between a larger group of 18 patients investigated before and after 1 year of treatment with omeprazole (0.806 +/- 0.1 vs. 0.93 +/- 0.08%) and between a larger group of 22 untreated patients and 17 patients treated for 17-24 months with omeprazole (0.73 +/- 0.1 vs. 0.86 +/- 0.09%). The volume density of argyrophilic cells found in 8 patients with gastrinoma amounted to 1.37 +/- 0.22%. No clusters of endocrine cells were found in omeprazole-treated patients. The D cell volume density in the antral mucosa decreased significantly during the first months of treatment, but steadily increased thereafter to reach pretreatment values after 17 months. There was no change in G cell volume density under therapy. No changes in gastrin levels or oxyntic argyrophilic cells were observed in the antrectomized patients. It is concluded that the hyperplasia of argyrophilic cells observed in some patients during long-term omeprazole treatment is mediated by hypergastrinaemia.